Autonomix Medical, Inc. (NASDAQ:AMIX – Get Free Report) was the recipient of a significant growth in short interest in May. As of May 29th, there was short interest totaling 646,074 shares, a growth of 230.7% from the May 14th total of 195,368 shares. Approximately 10.0% of the company’s stock are short sold. Based on an average daily volume of 4,028,480 shares, the short-interest ratio is presently 0.2 days.
Analysts Set New Price Targets
AMIX has been the subject of a number of research reports. Zacks Research upgraded shares of Autonomix Medical to a “hold” rating in a report on Tuesday, June 2nd. Maxim Group dropped their price objective on shares of Autonomix Medical from $5.00 to $2.00 and set a “buy” rating for the company in a report on Tuesday, February 17th. Finally, Weiss Ratings cut shares of Autonomix Medical from a “sell (e+)” rating to a “sell (e)” rating in a report on Wednesday, June 3rd. One analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $2.00.
Get Our Latest Stock Report on Autonomix Medical
Autonomix Medical Stock Down 0.9%
About Autonomix Medical
Autonomix Medical, Inc, a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.
Featured Articles
- Five stocks we like better than Autonomix Medical
- Time to Sell? 3 Winners With Fading Technical Momentum
- Why These 2 Hotel Stocks Are Beating Travel Peers
- This Energy Stock Has Quietly Soared 130% in a Year
- 3 ‘Boring’ Dividend Stocks With Tasty Technical Setups
Receive News & Ratings for Autonomix Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Autonomix Medical and related companies with MarketBeat.com's FREE daily email newsletter.
